Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers.

Neselius S, Zetterberg H, Blennow K, Marcusson J, Brisby H.

PLoS One. 2013 Nov 15;8(11):e81249. doi: 10.1371/journal.pone.0081249. eCollection 2013.

2.

CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma.

Neselius S, Brisby H, Theodorsson A, Blennow K, Zetterberg H, Marcusson J.

PLoS One. 2012;7(4):e33606. doi: 10.1371/journal.pone.0033606. Epub 2012 Apr 4.

3.

Neurochemical aftermath of amateur boxing.

Zetterberg H, Hietala MA, Jonsson M, Andreasen N, Styrud E, Karlsson I, Edman A, Popa C, Rasulzada A, Wahlund LO, Mehta PD, Rosengren L, Blennow K, Wallin A.

Arch Neurol. 2006 Sep;63(9):1277-80.

PMID:
16966505
4.

Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma.

Neselius S, Zetterberg H, Blennow K, Randall J, Wilson D, Marcusson J, Brisby H.

Brain Inj. 2013;27(4):425-33. doi: 10.3109/02699052.2012.750752. Epub 2013 Mar 8.

PMID:
23473386
5.

Neurological assessment and its relationship to CSF biomarkers in amateur boxers.

Neselius S, Brisby H, Marcusson J, Zetterberg H, Blennow K, Karlsson T.

PLoS One. 2014 Jun 18;9(6):e99870. doi: 10.1371/journal.pone.0099870. eCollection 2014.

6.

Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing.

Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S.

JAMA. 1997 Jul 9;278(2):136-40.

PMID:
9214529
7.

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.

Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.

Biol Psychiatry. 2004 Nov 1;56(9):670-6.

PMID:
15522251
8.

Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports.

Shahim P, Zetterberg H, Tegner Y, Blennow K.

Neurology. 2017 May 9;88(19):1788-1794. doi: 10.1212/WNL.0000000000003912. Epub 2017 Apr 12.

PMID:
28404801
9.

Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease.

Höglund K, Bogstedt A, Fabre S, Aziz A, Annas P, Basun H, Minthon L, Lannfelt L, Blennow K, Andreasen N.

J Alzheimers Dis. 2012;32(4):939-47. doi: 10.3233/JAD-2012-120976.

PMID:
22936008
10.

Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.

Wang XK, Zhang HL, Meng FH, Chang M, Wang YZ, Jin T, Mix E, Zhu J.

Neurol Sci. 2013 May;34(5):655-61. doi: 10.1007/s10072-012-1092-z. Epub 2012 Apr 22.

PMID:
22526766
11.

Correlation of mechanical impact responses and biomarker levels: A new model for biomarker evaluation in TBI.

Li Y, Zhang L, Kallakuri S, Cohen A, Cavanaugh JM.

J Neurol Sci. 2015 Dec 15;359(1-2):280-6. doi: 10.1016/j.jns.2015.08.035. Epub 2015 Sep 2.

PMID:
26671128
12.

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P.

Arch Neurol. 1998 Jul;55(7):937-45.

PMID:
9678311
13.

Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.

Huey ED, Mirza N, Putnam KT, Soares H, Csako G, Levy JA, Copenhaver B, Cohen RM, Sunderland T.

Dement Geriatr Cogn Disord. 2006;22(1):48-53. Epub 2006 May 8.

PMID:
16682793
14.

Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.

Sundelöf J, Sundström J, Hansson O, Eriksdotter-Jönhagen M, Giedraitis V, Larsson A, Degerman-Gunnarsson M, Ingelsson M, Minthon L, Blennow K, Kilander L, Basun H, Lannfelt L.

J Alzheimers Dis. 2010;21(2):471-8. doi: 10.3233/JAD-2010-091594.

PMID:
20555147
15.

Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment.

Andersson C, Blennow K, Johansson SE, Almkvist O, Engfeldt P, Lindau M, Eriksdotter-Jönhagen M.

Dement Geriatr Cogn Disord. 2007;23(2):87-95. Epub 2006 Nov 22.

PMID:
17124416
16.

Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes.

Bech S, Hjermind LE, Salvesen L, Nielsen JE, Heegaard NH, Jørgensen HL, Rosengren L, Blennow K, Zetterberg H, Winge K.

Parkinsonism Relat Disord. 2012 Jan;18(1):69-72. doi: 10.1016/j.parkreldis.2011.08.012. Epub 2011 Aug 27.

PMID:
21873100
17.

A prospective controlled study of cognitive function during an amateur boxing tournament.

Moriarity J, Collie A, Olson D, Buchanan J, Leary P, McStephen M, McCrory P.

Neurology. 2004 May 11;62(9):1497-502.

PMID:
15136671
18.

Six-month recovery from mild to moderate Traumatic Brain Injury: the role of APOE-epsilon4 allele.

Chamelian L, Reis M, Feinstein A.

Brain. 2004 Dec;127(Pt 12):2621-8. Epub 2004 Oct 20.

PMID:
15496436
19.

Monitoring concussion in a knocked-out boxer by CSF biomarker analysis.

Neselius S, Brisby H, Granholm F, Zetterberg H, Blennow K.

Knee Surg Sports Traumatol Arthrosc. 2015 Sep;23(9):2536-9. doi: 10.1007/s00167-014-3066-6. Epub 2014 May 13.

PMID:
24819180
20.

Elevated levels of phosphorylated neurofilament heavy subunit in the cerebrospinal fluid of patients with lumbar spinal stenosis: preliminary findings.

Ohya J, Chikuda H, Kato S, Hayakawa K, Oka H, Takeshita K, Tanaka S, Ogata T.

Spine J. 2015 Jul 1;15(7):1587-92. doi: 10.1016/j.spinee.2015.03.013. Epub 2015 Mar 20.

PMID:
25797810

Supplemental Content

Support Center